|
Cancer Research - NCI
NCI is the nation’s leader in cancer research. Learn about key research areas, initiatives, progress, and research tools, including specimens and data.
Common Terminology Criteria for Adverse Events (CTCAE)
Introduction The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE) reporting. A grading (severity) scale is provided for each AE term.
Advances in Pancreatic Cancer Research - NCI
Find what’s new in pancreatic cancer research, including current progress in treatment with stroma-modifying drugs and immunotherapy. Selected NCI-supported programs that address pancreatic cancer are also described.
CCR Milestones - 2026 | Center for Cancer Research
Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This digital-only issue of our annual publication, Milestones, features 14 of our top scientific advances from the past year. This issue of Milestones highlights some of our scientific advances in FY 2025-2026.
Advances in Prostate Cancer Research - NCI
Find what's new in prostate cancer research, including current progress in improving biopsies and imaging for diagnosis, and in treating prostate cancer with hormone therapy, immunotherapy, and targeted therapy. Selected NCI-supported programs are also described.
Advances in Melanoma and Other Skin Cancers Research
This page highlights some of the latest research in treatment for melanoma and other skin cancers, including clinical advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and current research findings from recent studies.
NCI study challenges long-held beliefs about cell division
NCI’s intramural research program conducts innovative, transdisciplinary basic, translational, clinical, and epidemiological research on the causes of cancer, avenues for prevention, risk prediction, early detection, and treatment, including research at the NIH Clinical Center—the world’s largest research hospital.
One Year in Cancer Research and Much to Celebrate
NCI Director Dr. Kimryn Rathmell reviews some of the most noteworthy cancer research findings from 2024, including advances in immunotherapy for children with cancer, a potential therapy for cachexia, and valuable insights into cancer biology.
Milestones in Cancer Research and Discovery - NCI
During the past 250 years, we have witnessed many landmark discoveries in our efforts to make progress against cancer, an affliction known to humanity for thousands of years. This timeline shows a few key milestones in the history of cancer research.
Advances in Colorectal Cancer Research - NCI
Find what's new in colorectal cancer research, including progress related to the prevention, early detection, and treatment of colorectal cancer, plus current research programs supported by NCI.
|
